Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients.

by Philip, T., Negrier, S., Lasset, C., Coronel, B., Bret, M., Blay, J. Y., Merrouche, Y., Carrie, C., Kaemmerlen, P., Chauvin, F.
Published 1993

Is neuroblastoma screening evaluation needed and feasible?

by Estève, J., Parker, L., Roy, P., Herrmann, F., Duffy, S., Frappaz, D., Lasset, C., Hill, C., Sancho-Garnier, H., Michaelis, J.
Published 1995

Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring.

by Blay, J. Y., Lasset, C., Carrie, C., Chauvin, F., Coiffier, B., Gisselbrecht, C., Clavel, M., Rebattu, P., Brunat-Mentigny, M., Philip, T.
Published 1993

Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression.

by Combaret, V., Gross, N., Lasset, C., Balmas, K., Bouvier, R., Frappaz, D., Beretta-Brognara, C., Philip, T., Favrot, M. C., Coll, J. L.
Published 1997

Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma.

by Bain, C., Merrouche, Y., Puisieux, I., Blay, J. Y., Negrier, S., Bonadona, V., Lasset, C., Lanier, F., Duc, A., Gebuhrer, L., Philip, T., Favrot, M. C.
Published 1997